Ventana Partners to Develop Companion Diagnostic Test Based on CD30 Expression Levels
Ventana will seek to develop, manufacture, and commercialize a molecular companion diagnostic test with the goal of identifying patients who might respond to treatment with ADCETRIS based on CD30 expression levels in their tissue specimens.
Read More